Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

fbg0316, "...investors under the new CEO's watch have seen their investment erode 30%." This is a VERY COMMON occurrence in early stage, pre-revenue companies. Investors at $12 are not at all unhappy with what they bought because they could CARE LESS about the share price between now and when the final bell rings. The "final bell" always has been: (1) successful AXAL Ph3 and FDA approval, and (2) more general validation of the Lm platform.

I repeat: any serious investor could CARE LESS what happens to share price between now and then. They only hope that Dan raises capital when price is higher rather than lower.

If you want a consistently increasing share price, you need to invest in ETFs (which you mention as comparisons). But, you'll never 5x-10x your investment with an ETF within 5-10 years.